Antiangiogenic agents in cancer therapy, 2d ed.9781588298706 Antiangiogenic an·ti·an·gi·o·gen·ic adj. Inhibiting the growth of blood vessels. antiangiogenic agents in cancer therapy, 2d ed. Ed. by Beverly A. Teicher and Lee M. Ellis. Humana Press Inc. 2008 559 pages $169.00 Hardcover Cancer drug discovery and development RC271 This work reviews the latest findings and approaches in the use of antiangiogenic agents in cancer treatment. Material is in sections on basic biology of angiogenesis angiogenesis /an·gio·gen·e·sis/ (-jen´e-sis) vasculogenesis; development of blood vessels either in the embryo or in the form of neovascularization or revascularization. an·gi·o·gen·e·sis n. , translational research in tumor tumor: see neoplasm. angiogenesis, and antiangiogenic therapy Antiangiogenic Therapy Definition Antiangiogenesis therapy is one of two types of drugs in a new class of medicines that restores health by controlling blood vessel growth. The other medication is called pro-angiogenic therapy. in clinical trial results and future directions. Chapters cover topics such as working models of tumor angiogenesis, the role of angiogenesis inhibition in the therapy of malignant disease, and the environmental influences and genetic and physiologic abnormalities that mediate MEDIATE, POWERS. Those incident to primary powers, given by a principal to his agent. For example, the general authority given to collect, receive and pay debts due by or to the principal is a primary power. angiogenesis and its role in the progression of malignant disease. Other subjects examined include chemokines in angiogenesis, small-molecule vascular disrupting agents in cancer therapy, and the role of imaging in the clinical development of antiangiogenic agents. Teicher is affiliated with Genzyme Corporation. Ellis is affiliated with the University of Texas M. D. Anderson Cancer Center. ([c]20082005 Book News, Inc., Portland, OR) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion